Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin for bowel deep infiltrating endometriosis adhesiolysis during laparoscopy
IRCT20091012002576N27Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vasopressin in endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Time of surgery, Bleeding and 3 more. Started Jan 2023; status: completed.
02
Drugs
vasopressin
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20091012002576N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N27.